ZELTIQ to Present at the Canaccord Genuity 35th Annual Growth Conference
(firmenpresse) - PLEASANTON, CA -- (Marketwired) -- 08/11/15 -- ZELTIQ® (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that Mark Foley, President and Chief Executive Officer is scheduled to present at the Canaccord Genuity 35th Annual Growth Conference in Boston, MA.
Canaccord Genuity 35th Annual Growth ConferenceWednesday, August 12, 2015
3:30 pm ET / 12:30 pm PT
Audio webcasts of the Company''s presentations will be available by visiting the investor relations section of ZELTIQ''s web site at . Replays of the presentations will be available for 90 days.
ZELTIQ is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. ZELTIQ''s first commercial product, the CoolSculpting® System, is designed to selectively reduce stubborn fat bulges. CoolSculpting is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues. It utilizes patented technology of precisely controlled cooling to reduce the temperature of fat cells in the treated area, which is intended to cause fat cell elimination through a natural biological process known as apoptosis. ZELTIQ developed CoolSculpting to safely, noticeably, and measurably reduce the fat layer.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 11.08.2015 - 17:50 Uhr
Sprache: Deutsch
News-ID 1378416
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
PLEASANTON, CA
Phone:
Kategorie:
Personal Care & Fitness
Anmerkungen:
Diese Pressemitteilung wurde bisher 253 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"ZELTIQ to Present at the Canaccord Genuity 35th Annual Growth Conference
"
steht unter der journalistisch-redaktionellen Verantwortung von
ZELTIQ Aesthetics, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
